News

Xeris Biopharma Preparing for Upcoming Financial Results Call

Xeris Biopharma Preparing for Upcoming Financial Results Call

Xeris Biopharma Plans Financial Results Announcement

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS) has exciting news for investors and stakeholders alike. This growth-focused biopharmaceutical company is dedicated to enhancing patients' lives through the development and marketing of innovative therapies. They've announced their intention to release third quarter 2024 financial results before the markets open on a notable day in November.

Conference Call Details

On the designated date, Xeris management will host a conference call and webcast at 8:30 a.m. Eastern Time. This session will provide a comprehensive overview of the company’s financial and operational performance for the quarter. Stakeholders are encouraged to tune in to learn more about the company's milestones and future outlook.

How to Pre-register for the Call

Interested parties can pre-register for the conference call by visiting the dedicated link provided in the company's official announcements. It is advisable to register at least ten minutes prior to the start to ensure a smooth entry into the session. Participants will receive a confirmation email with important dial-in information and a unique entry code.

Replay and Access Information

For those who are unable to attend the live call, a replay will be accessible for a limited time. Callers can access the replay through various numbers tailored for different locations, ensuring everyone has the opportunity to stay informed about the company's developments.

About Xeris Biopharma Holdings

Xeris stands committed to developing and commercializing a diverse range of innovative products aimed at treating various health concerns. Currently, their portfolio includes three commercially available products. Notable among them is Gvoke®, a ready-to-use liquid glucagon designed to counter severe hypoglycemia.

Pipeline of Innovative Therapies

Additionally, Xeris offers Keveyis®, a proven treatment for primary periodic paralysis, alongside Recorlev®, which is used in managing endogenous Cushing’s syndrome. The company continues to expand its product range with a robust pipeline that leverages its proprietary formulation technologies, XeriSol™ and XeriJect®. This strategic approach allows Xeris to create therapies that are not only effective but also user-friendly.

Company Mission and Vision

Located in Chicago, Xeris Biopharma is deeply rooted in its mission to improve patients' lives. The company strives to enhance medication delivery methods, making treatments more accessible and manageable for patients with chronic conditions. Their innovative mindset positions them as key players in the biopharmaceutical landscape, and they are consistently seeking new opportunities to expand their influence.

Frequently Asked Questions

What is the date of the upcoming financial results announcement?

The financial results for the third quarter of 2024 will be announced before the market opens on November 8, 2024.

Will there be a conference call?

Yes, there will be a conference call hosted by Xeris Biopharma management on the same day at 8:30 a.m. Eastern Time.

How can I participate in the conference call?

Participants can pre-register for the call through the link provided in the financial announcement and should do so at least ten minutes prior to the start.

What products are included in Xeris' portfolio?

Xeris offers Gvoke®, Keveyis®, and Recorlev®, addressing various medical needs in the biopharmaceutical sector.

What is the company’s focus?

Xeris focuses on developing innovative therapies that enhance patients’ lives through improved product formulation and delivery methods.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Krispy Kreme Faces Legal Probe: Fiduciary Breach?

Updated Category News Views 3

Diving Deep into the Krispy Kreme Allegations Look, this isn't your run-of-the-mill donut drama. When you hear rumblings of corporate missteps, especially ones that involve potential breaches of fiduciary duties, it's time to perk up those ears. Over at Krispy Kreme, Inc. (NASDAQ:DNUT), there's some heat in the kitchen, and it's not just from frying those glazed beauties....

Continue Reading
Jackson Wang's Fantasy IP Hits Hong Kong Stage

Updated Category News Views 5

A Star-Studded Fantasy Comes Alive Hong Kong isn't just about dim sum and skyline views—it's a magnet for celebrity showcases, and this time, Jackson Wang's pulling the strings. The guy's ventured beyond music and idol fame, diving head-first into creative visuals with his fantasy IP, "Under the Castle" (UTC). Pairing up with Ocean Park's Halloween Fest, he's cooked up...

Continue Reading
CVS Health Under Fire: Fiduciary Duty Breach?

Updated Category News Views 2

CVS Under Regulatory Spotlight for Fiduciary Breaches You'd think by now companies would have their fiduciary ducks in a row. But here we are, with CVS Health Corporation (NYSE: CVS) catching heat from the legal eagles over at Halper Sadeh LLC. The knife’s out for some of the big wigs – apparently, there's chatter they might’ve slipped on their duty to play nice...

Continue Reading
PACS Group Faces Legal Scrutiny: What to Watch

Updated Category News Views 4

PACS Group: Legal Storm Brewing Welcome to the latest saga in the volatile theater of corporate governance. PACS Group, Inc., ticker symbol NYSE:PACS, is under the microscope, and not for debuting a groundbreaking product or hitting a stock milestone. Nope, instead we've got Halper Sadeh LLC out of New York investigating some possible hanky-panky from PACS directors and...

Continue Reading
China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 3

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading
Timur Turlov Leads FIDE with Chess and Digital Focus

Updated Category News Views 2

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Continue Reading
Quay Sunglasses: Luxury Looks, Affordable Prices

Updated Category News Views 3

Ah, sunglasses—the quintessential accessory that screams both practicality and style. A million-dollar look without the million-dollar expense? That's where Quay comes in. They've been recognized by Expert Consumers, no less, as some of the best-in-class for affordable luxury eye candy out there—aimed at shoppers who want the designer vibe without the hemorrhaging...

Continue Reading
HONA Faces Legal Heat: Investor Lawsuit Over Losses

Updated Category News Views 6

The Investor Storm Brewing Over Honeywell Aerospace There it is again, another industry heavyweight caught in a dizzying whirlwind of litigation. Honeywell Aerospace Inc. (NASDAQ:HONA), a name as established as an old boot in the business, now faces a class action lawsuit that's got investors frantically dusting off phone numbers for their attorneys. The Messy Allegations...

Continue Reading
Geron Corp Faces Fiduciary Duty Investigation

Updated Category News Views 7

Spotlight on Geron's Corporate Governance: What's Happening? The heat's been turned up on Geron Corporation this week, with Halper Sadeh LLC, an investor rights law outfit, digging into whether some folks at the helm have strayed from their fiduciary duties to the shareholders. Now, if you're holding onto NASDAQ:GERN stock or thinking about diving in, it's high time to...

Continue Reading
AI and Storytelling Make Waves in Science Education

Updated Category News Views 5

University's Innovative Approach to Learning Alright, here's something you don't see every day. The University of Phoenix managed to snag some kudos from an academic journal for using AI and storytelling to teach environmental science. That's like hitting two bulls-eyes with one shot in the world of education. The recognition from Glacies for this Editor's Choice paper...

Continue Reading

Top 5 Most Recently Viewed Articles

Cholesterol Testing Market Growth Projections to 2033

Updated Category News Views 98

The cholesterol testing market witnessed massive growth starting back in 2024 when it was valued at USD 109.8 billion. By 2033, projections showed it skyrocketing to USD 247.5 billion as awareness around cardiovascular health started heating up. Market Drivers: Age and Awareness Surge As the years rolled on, more folks aged and with that came higher risks of heart...

Continue Reading
Elon Musk Highlights Risks for American Airlines and Their Customers

Updated Category News Views 79

Elon Musk's Warning to American Airlines Elon Musk, the dynamic CEO of SpaceX, has voiced concerns regarding American Airlines Group Inc. (NASDAQ: AAL), stating that the airline could face significant customer loss if its in-flight internet service does not meet expectations. The Importance of Connectivity In response to a statement from Michael Nicolls, Starlink's VP of...

Continue Reading
Legal Innovators Launches Career Opportunities for New Attorneys

Updated Category News Views 131

Exciting Career Opportunities for Law Students Third-year and evening law students are invited to explore a unique opportunity designed to support and guide them into prestigious law firms and corporate legal departments. Legal Innovators is on the lookout for third-year law students and evening students for their innovative program. This program is tailored to assist...

Continue Reading
ALT5 Sigma Faces Major Governance Challenges Amid Fallout

Updated Category News Views 143

ALT5 Sigma Faces Major Governance Challenges Amid a turbulent period for ALT5 Sigma Corporation (NASDAQ: ALTS), significant concerns have emerged surrounding the company's governance practices and financial reporting. With the stock taking a steep nosedive of nearly 80%, the spotlight has turned to the internal operations of the firm, prompting investigations into...

Continue Reading
AI-Driven Growth in the Lignocellulosic Biofuel Market

Updated Category News Views 67

AI-Driven Growth in the Lignocellulosic Biofuel Market The global market for biofuels made from lignocellulosic feedstock is set for significant growth, with projections estimating an increase of USD 33.6 billion from 2024 to 2028. This exciting forecast, spurred on by breakthroughs in artificial intelligence (AI), suggests we are entering a new era for biofuels—one...

Continue Reading